ImmuCell Corporation (ICCC)

NCM – Real Time Price. Currency in USD

10.98

+0.03 (0.27%)

Market open: Aug 12, 2026, 1:50 PM EDT

10.95

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 4:10 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

06.08.2026

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026

PORTLAND, Maine, Aug. 06, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity, expects to report unaudited financial results for the quarter ended June 30, 2026 after the market closes on Thursday, August 13, 2026. The Company is planning to host a conference call and webcast on August 14, 2026, at 9:00 AM ET to review the unaudited financial results.

Videos

No Data

There is no data to display

ImmuCell Corporation (ICCC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ImmuCell Corporation (ICCC)

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026

Videos

No Data

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026

Videos

No Data

Search stocks

ImmuCell Corporation (ICCC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ImmuCell Corporation (ICCC)

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026

Videos

No Data

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026

Videos

No Data